Company

Haystack MRD™ by Quest Diagnostics®

Biotechnology Research 2004u, De 54 employees

Employees: 54

www.haystackmrd.com LinkedIn Crunchbase

Haystack MRD™ by Quest Diagnostics® Overview

Headquarters: 2004u, De
Website: www.haystackmrd.com
Industry: Biotechnology Research
Employees: 54
Founded: 2021
Funding: 56.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

About Haystack MRD™ by Quest Diagnostics®

Haystack MRD™ by Quest Diagnostics is a tumor-informed, next-generation minimal residual disease (MRD) test that detects ultralow levels of circulating tumor DNA (ctDNA) to uncover residual disease after cancer treatment. Based on more than 20 years of clinical development and technology from pioneers in cancer genomics at Johns Hopkins University, Haystack MRD's purpose-built, high-precision science delivers novel insights that can help inform treatment decision-making.

Haystack MRD™ by Quest Diagnostics® Contact Details

People in AeroLeads: 4

Haystack MRD™ by Quest Diagnostics® Org Chart

Sample employees and titles

Name	Title	Location	Contact
Robyn Sussman, Ph.d.	Senior Manager of Product Research	Greater Philadelphia, United States	View
Frank Holtrup	Chief Technology Officer at Haystack		View
Christian Gloeckner	Sr. Director - Business Development		View
Hilary Vantassell	Scientific Writer - Medical Writer		View